The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global therapeutic beds market size reached US$ 4.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2027, exhibiting a growth rate (CAGR) of 5.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Clinical therapeutic beds are specially designed beds that provide maximum patient comfort and improve healthcare delivery. These beds are intended to be used in controlled clinical environments, such as nursing homes, diagnostic laboratories, and outpatient clinics. Additional positioning aids, such as pads, pillows, and wedges, are also included with these adjustable beds. When compared to regular beds, these beds and mattresses are designed to lower acupoints, regulate body temperature, prevent bedsores, and improve blood flow. In addition to this, they are equipped with advanced features, such as electronic elevation, side rails, and wheels, thereby providing portability and safety for patients. In the event of surgery, injury, or degenerative disease, therapy beds fulfill the comfort and positioning needs associated with the medical condition.
The global market is majorly driven by continual technological advancements in the healthcare sector. This can be attributed to the extensive research and development (R&D) activities conducted by the key players focusing on introducing innovative product variants. In addition to this, a considerable rise in consumer awareness regarding health and wellness is acting as a significant growth-inducing factor for the market. The market is further propelled by the rising geriatric population susceptible to developing several chronic illnesses and requiring longer hospital stays. In line with this, the expanding medical expenditure and growing funding by public and private agencies to improve the overall healthcare infrastructure are acting as other major growth-inducing factors. Some of the other factors contributing to the market include the escalating demand for preoperative and postoperative critical care services, the rising prevalence of lifestyle-related diseases, growing expenditure on patient care, and increasing investments for improving the number of beds to patient ratio.
IMARC Group provides an analysis of the key trends in each sub-segment of the global therapeutic beds market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at